Antimicrobial resistance: the silent crisis shaping global health

Antimicrobial resistance (AMR) is one of the most consequential health challenges worldwide. As microbes evolve to survive exposure to antibiotics, antivirals, antifungals and antiparasitics, routine infections become harder to treat, medical procedures grow riskier, and health systems face mounting costs and complexity.

Why AMR matters
AMR undermines treatments across the care continuum. Common surgeries, chemotherapy, and care for premature infants rely on effective antimicrobials to prevent and treat infections. When first-line drugs fail, patients need longer, more toxic, and more expensive therapies. Beyond individual health, unchecked resistance threatens food security, trade, and economic stability through impacts on livestock production and workforce productivity.

Main drivers
– Overuse and misuse of antimicrobials in human medicine, such as unnecessary prescriptions for viral illnesses or incomplete treatment courses.
– Routine use of antibiotics for growth promotion and disease prevention in animal agriculture in settings lacking strong stewardship.
– Poor infection prevention and control in healthcare facilities and communities, allowing resistant strains to spread.
– Environmental contamination from pharmaceutical manufacturing, agricultural runoff, and inadequate wastewater treatment that exposes microbes to low drug concentrations and selects for resistance.
– Limited access to rapid diagnostics and new drugs, creating pressure to rely on broad-spectrum agents.

High-impact strategies
A coordinated, multisectoral approach is essential.

Key strategies include:

– Strengthen antibiotic stewardship: Encourage diagnostics-guided prescribing, set stewardship programs in hospitals and clinics, and educate providers and the public about appropriate use.
– Expand rapid diagnostics: Point-of-care tests that distinguish bacterial from viral infections and identify resistance markers reduce unnecessary antibiotic use and guide targeted therapy.
– Improve infection prevention: Vaccination, hand hygiene, safe delivery practices, and better sanitation reduce the burden of infections and the need for antimicrobials.
– Reform agricultural practices: Phase out routine antibiotic use for growth promotion, adopt veterinary stewardship, and promote husbandry practices that lower disease risk.
– Invest in wastewater and environmental controls: Upgrading wastewater treatment and regulating pharmaceutical effluents help prevent environmental selection of resistant organisms.
– Incentivize R&D: New financial models and regulatory pathways are needed to stimulate development of novel antimicrobials, alternative therapies, and rapid diagnostics while ensuring equitable access.
– Strengthen surveillance: Integrated human, animal, and environmental surveillance provides early warning on emerging resistance trends and guides policy.

What individuals can do
– Follow prescriptions exactly, finish full courses unless advised otherwise, and never use leftover antibiotics for a new illness.
– Avoid requesting antibiotics for viral illnesses such as colds and most sore throats.
– Keep vaccinations up to date and practice regular hygiene to reduce infection risk.
– Support sustainable food choices: seek meat raised without routine antibiotic use, and ask retailers and producers about stewardship practices.

Policy and global cooperation

global health image

Effective responses require alignment across ministries of health, agriculture, environment, finance and trade.

National action plans that integrate One Health principles—recognizing the links between people, animals and the environment—are central. Global collaboration to share surveillance data, harmonize regulatory standards and finance access to new tools will protect health equity and economic resilience.

AMR control is not a single intervention but a long-term, systems-level effort. By combining stewardship, prevention, innovation and cross-sector cooperation, it’s possible to slow resistance, preserve treatment options and protect the gains of modern medicine.